Detalhe da pesquisa
1.
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
N Engl J Med
; 386(10): 951-963, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045226
2.
Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans.
J Virol
; 98(3): e0185023, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415596
3.
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination.
J Infect Dis
; 227(5): 651-662, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402141
4.
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
Clin Infect Dis
; 76(3): e533-e536, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723273
5.
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Clin Infect Dis
; 76(3): e188-e199, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796536
6.
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
PLoS Med
; 20(1): e1004159, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608645
7.
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.
Am J Transplant
; 23(9): 1411-1424, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270109
8.
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
J Allergy Clin Immunol
; 149(6): 1949-1957, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421449
9.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
PLoS Med
; 19(10): e1003979, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301821
10.
A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial.
Vaccine
; 41(43): 6495-6504, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726181
11.
Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic disease.
mSphere
; 8(4): e0008223, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377421
12.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Lancet Infect Dis
; 23(8): 901-913, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088096
13.
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.
NPJ Vaccines
; 8(1): 70, 2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198189
14.
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
iScience
; 26(1): 105753, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507223
15.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Lancet Infect Dis
; 23(3): 307-319, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36354032
16.
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern.
mBio
; 13(3): e0124922, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695453
17.
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
Front Immunol
; 13: 1067749, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524126
18.
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.
Sci Immunol
; 7(69): eabo2202, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113647
19.
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Transplantation
; 106(4): 821-834, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753894
20.
From A to m6A: The Emerging Viral Epitranscriptome.
Viruses
; 13(6)2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34205979